Development of HER2-targeted nanobodies for molecular optical imaging and therapy of breast cancer

Biochemistry, Genetics and Molecular Biology

• Optical Imaging 100%
• Single-Domain Antibody 100%
• Trastuzumab 20%
• Monoclonal Antibody 15%
• Ribonuclease 5%
• RNA 5%
• Infrared Radiation 5%
• In Vivo Study 5%
• Electron Microscopy 5%
• Heavy Chain 5%
• Photodynamics 5%
• Enzyme 5%
• Cancer Cell 5%
• Staining 5%
• Camelid 5%
• Canis 5%

Keyphrases

• HER2 Targeting 100%
• Optical Therapy 100%
• Molecular Status 10%
• HER2-negative 10%
• Trastuzumab/Herceptin 5%
• Breast Cancer Tumor 5%
• Radiation-based Therapies 5%

Immunology and Microbiology

• Single-Domain Antibody 100%
• Trastuzumab 20%
• Monoclonal Antibody 15%
• Antigen 5%
• Electron Microscopy 5%
• Canis 5%
• Photodynamics 5%
• Cancer Cell 5%
• Staining 5%
• Camelid 5%
• Heavy Chain 5%
• Infrared Radiation 5%
• Ribonucleic Acid 5%